Neurocrine Biosciences (NBIX) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $149.50 --0%
EPS Growth %: -12.4%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -12.4%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- UBS Reiterates Sell Rating on Macy's (M) on Price Challenges Vs. Peers
- Copart launches $10.50-per-share tender offer to acquire ACV
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
